CD4+/CD8+ T-Cell Ratio Predictive of Surgical Margins in the Treatment of Nonmelanoma Skin Cancer Treated With Mohs Surgery of Patients Infected With the Human Immunodeficiency Virus

Dermatol Surg. 2021 Jun 1;47(6):817-818. doi: 10.1097/DSS.0000000000002702.
No abstract available

MeSH terms

  • CD4-CD8 Ratio*
  • Carcinoma, Basal Cell / blood
  • Carcinoma, Basal Cell / immunology
  • Carcinoma, Basal Cell / pathology
  • Carcinoma, Basal Cell / surgery*
  • Carcinoma, Squamous Cell / blood
  • Carcinoma, Squamous Cell / immunology
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / surgery*
  • Female
  • HIV Infections / blood
  • HIV Infections / complications*
  • HIV Infections / immunology
  • Humans
  • Male
  • Margins of Excision
  • Middle Aged
  • Mohs Surgery / statistics & numerical data
  • Predictive Value of Tests
  • Retrospective Studies
  • Skin / pathology
  • Skin Neoplasms / blood
  • Skin Neoplasms / immunology*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery
  • Tumor Burden / immunology